Detalhe da pesquisa
1.
A genome-wide association study of chronic spontaneous urticaria risk and heterogeneity.
J Allergy Clin Immunol;
151(5): 1351-1356, 2023 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36343773
2.
Exacerbation Profile and Risk Factors in a Type-2-Low Enriched Severe Asthma Cohort: A Clinical Trial to Assess Asthma Exacerbation Phenotypes.
Am J Respir Crit Care Med;
206(5): 545-553, 2022 09 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35549845
3.
Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma.
Eur Respir J;
59(4)2022 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34561291
4.
Impact of body mass index on omalizumab response in adults with moderate-to-severe allergic asthma.
Ann Allergy Asthma Immunol;
128(5): 553-560, 2022 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35101644
5.
Urinary Leukotriene E4 and Prostaglandin D2 Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type 2 Inflammation. A Clinical Observational Study.
Am J Respir Crit Care Med;
203(1): 37-53, 2021 01 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32667261
6.
Patients with allergic asthma have lower risk of severe COVID-19 outcomes than patients with nonallergic asthma.
BMC Pulm Med;
22(1): 418, 2022 Nov 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36376851
7.
Racial/ethnic differences in eligibility for asthma biologics among pediatric populations.
J Allergy Clin Immunol;
148(5): 1324-1331.e12, 2021 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34536416
8.
Overlap of allergic, eosinophilic and type 2 inflammatory subtypes in moderate-to-severe asthma.
Clin Exp Allergy;
51(4): 546-555, 2021 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33217063
9.
Omalizumab response in patients with asthma by number and type of allergen.
Ann Allergy Asthma Immunol;
127(2): 223-231, 2021 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33838339
10.
No difference in omalizumab efficacy in patients with asthma by number of asthma-related and allergic comorbidities.
Ann Allergy Asthma Immunol;
126(6): 666-673, 2021 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33465457
11.
A randomized, placebo-controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER).
Clin Exp Allergy;
50(12): 1342-1351, 2020 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32909660
12.
Change in biomarkers of type-2 inflammation following severe exacerbations of asthma.
Thorax;
74(1): 95-98, 2019 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30021810
13.
Change in type-2 biomarkers and related cytokines with prednisolone in uncontrolled severe oral corticosteroid dependent asthmatics: an interventional open-label study.
Thorax;
74(8): 806-809, 2019 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30940770
14.
Sputum periostin is a biomarker of type 2 inflammation but not airway dysfunction in asthma.
Respirology;
28(5): 491-494, 2023 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36914406
15.
Relationships among aeroallergen sensitization, peripheral blood eosinophils, and periostin in pediatric asthma development.
J Allergy Clin Immunol;
139(3): 790-796, 2017 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27484037
16.
High density lipoproteins and type 2 inflammatory biomarkers are negatively correlated in atopic asthmatics.
J Lipid Res;
58(8): 1713-1721, 2017 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28655726
17.
Model-based clinical pharmacology profiling and exposure-response relationships of the efficacy and biomarker of lebrikizumab in patients with moderate-to-severe asthma.
Pulm Pharmacol Ther;
46: 88-98, 2017 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28843617
18.
Roles of Periostin in Respiratory Disorders.
Am J Respir Crit Care Med;
193(9): 949-56, 2016 05 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26756066
19.
Periostin levels and eosinophilic inflammation in poorly-controlled asthma.
BMC Pulm Med;
16(1): 67, 2016 Apr 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27130294
20.
Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies.
Thorax;
70(8): 748-56, 2015 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26001563